Financhill
Sell
25

BZFD Quote, Financials, Valuation and Earnings

Last price:
$2.92
Seasonality move :
7.01%
Day range:
$2.88 - $3.14
52-week range:
$0.64 - $5.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.47x
P/B ratio:
1.55x
Volume:
640.5K
Avg. volume:
1.6M
1-year change:
138.56%
Market cap:
$111M
Revenue:
$252.7M
EPS (TTM):
-$1.00
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $317.9M $321.3M $383.8M $342.6M $252.7M
Revenue Growth (YoY) 3.47% 1.07% 19.45% -10.75% -26.24%
 
Cost of Revenues $150.4M $140.3M $199M $194.3M $142.4M
Gross Profit $167.6M $181M $184.8M $148.2M $110.3M
Gross Profit Margin 52.71% 56.34% 48.15% 43.27% 43.66%
 
R&D Expenses $21.1M $17.7M $24.7M $27.1M $11.2M
Selling, General & Admin $167.3M $133.7M $161.9M $158.7M $117M
Other Inc / (Exp) $1.6M $882K $27.5M -$60.3M -$2.8M
Operating Expenses $207.8M $168.9M $208.7M $210.1M $150.1M
Operating Income -$40.3M $12.1M -$23.9M -$61.9M -$39.8M
 
Net Interest Expenses -- $923K $2.5M $15.6M $16.1M
EBT. Incl. Unusual Items -$37.3M $12.1M $1.1M -$137.8M -$58.7M
Earnings of Discontinued Ops. -- -- $22M -$60.8M -$29M
Income Tax Expense -$358K $941K -$2.7M $2.7M $1.6M
Net Income to Company -$36.9M $11.2M $3.9M -$140.5M -$60.3M
 
Minority Interest in Earnings -$273K -$820K -$1.2M $369K $743K
Net Income to Common Excl Extra Items -$37.2M $10.3M $24.7M -$201M -$88.6M
 
Basic EPS (Cont. Ops) -$1.12 -- -- -$5.80 -$2.48
Diluted EPS (Cont. Ops) -$1.12 -- -$0.12 -$5.80 -$2.48
Weighted Average Basic Share $33.3M $33.3M $6.8M $34.5M $35.8M
Weighted Average Diluted Share $33.3M $33.3M $7M $34.5M $35.8M
 
EBITDA -$20.8M $30.5M $25.7M -$97.9M -$20.7M
EBIT -$40.3M $13M $3.6M -$122.2M -$42.6M
 
Revenue (Reported) $317.9M $321.3M $383.8M $342.6M $252.7M
Operating Income (Reported) -$40.3M $12.1M -$23.9M -$61.9M -$39.8M
Operating Income (Adjusted) -$40.3M $13M $3.6M -$122.2M -$42.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $75.2M $90.1M $103.7M $60M $64.3M
Revenue Growth (YoY) -- 19.74% 15.14% -42.18% 7.24%
 
Cost of Revenues $33.4M $48.8M $61M $31.9M $33.7M
Gross Profit $41.9M $41.3M $42.7M $28.1M $30.6M
Gross Profit Margin 55.62% 45.8% 41.21% 46.81% 47.61%
 
R&D Expenses $5.1M $5.7M $5.9M $2.4M $2.6M
Selling, General & Admin $34.3M $31M $43.6M $27M $19.5M
Other Inc / (Exp) -$258K -$2.6M -$5M -$1.2M $2.3M
Operating Expenses $43.7M $42.1M $58.7M $34.8M $27M
Operating Income -$1.9M -$881K -$15.9M -$6.7M $3.6M
 
Net Interest Expenses -- $487K $5.2M $4.1M $4M
EBT. Incl. Unusual Items -$2.1M -$3.9M -$26.1M -$12M $1.9M
Earnings of Discontinued Ops. -- -- -- -$1.9M $166K
Income Tax Expense -$12K -$353K $890K $55K -$110K
Net Income to Company -- -$3.6M -$27M -$12M $2M
 
Minority Interest in Earnings -$62K -$204K $137K $210K -$45K
Net Income to Common Excl Extra Items -$2.2M -$3.8M -$26.9M -$13.7M $2.1M
 
Basic EPS (Cont. Ops) -$0.07 -$0.11 -$0.76 -$0.38 $0.06
Diluted EPS (Cont. Ops) -$0.07 -$0.11 -$0.76 -$0.38 $0.06
Weighted Average Basic Share $33.3M $33.3M $34.7M $36.3M $37.9M
Weighted Average Diluted Share $33.3M $33.3M $34.7M $36.3M $38.6M
 
EBITDA $2.5M $2M -$11.7M -$2.5M $10.9M
EBIT -$1.9M -$3.4M -$20.9M -$7.9M $5.9M
 
Revenue (Reported) $75.2M $90.1M $103.7M $60M $64.3M
Operating Income (Reported) -$1.9M -$881K -$15.9M -$6.7M $3.6M
Operating Income (Adjusted) -$1.9M -$3.4M -$20.9M -$7.9M $5.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $374.9M $434M $217.5M $231.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $182.5M $246.4M $119.1M $124M
Gross Profit -- $192.4M $187.6M $98.4M $107.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $23.9M $28.7M $12.7M $10.8M
Selling, General & Admin -- $132.8M $207.7M $104.8M $89.2M
Other Inc / (Exp) $244K -$1.3M $28.3M -$63.6M $4.7M
Operating Expenses -- $175.7M $269.7M $131.8M $121.3M
Operating Income -- $16.7M -$82.2M -$33.4M -$13.6M
 
Net Interest Expenses -- $1.1M $16.4M $12.4M $16.8M
EBT. Incl. Unusual Items -- $13.3M -$70.3M -$109.4M -$25.7M
Earnings of Discontinued Ops. -- -- -- -$14.1M -$24.8M
Income Tax Expense -- -$3.3M $5.3M -$168K $1.8M
Net Income to Company -- -- -$75.6M -$109.3M -$27.5M
 
Minority Interest in Earnings -$385K -$91K -$1.5M $1.2M $154K
Net Income to Common Excl Extra Items -- $16.5M -$55.1M -$183M -$52.1M
 
Basic EPS (Cont. Ops) -- $0.19 -$2.72 -$5.18 -$1.00
Diluted EPS (Cont. Ops) -- $0.19 -$2.74 -$5.18 -$1.00
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- $34.8M -$20.6M -$82.6M $12.4M
EBIT -- $15.8M -$53.9M -$97M -$8.9M
 
Revenue (Reported) -- $374.9M $434M $217.5M $231.7M
Operating Income (Reported) -- $16.7M -$82.2M -$33.4M -$13.6M
Operating Income (Adjusted) -- $15.8M -$53.9M -$97M -$8.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $134.4M $251.8M $302.1M $177M $156M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $61.2M $135.9M $183.3M $108.1M $89.8M
Gross Profit $73.2M $115.9M $118.7M $68.9M $66.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $9.1M $19.3M $23.3M $8.9M $8.5M
Selling, General & Admin $63.4M $99.4M $145.2M $91.2M $63.4M
Other Inc / (Exp) $244K -$1.8M -$1M -$4.3M $3.3M
Operating Expenses $81.5M $133.8M $194.8M $116.5M $87.7M
Operating Income -$8.4M -$17.8M -$76.1M -$47.6M -$21.4M
 
Net Interest Expenses -- $1.1M $15M $11.8M $12.5M
EBT. Incl. Unusual Items -$8.1M -$20.7M -$92.1M -$63.8M -$30.7M
Earnings of Discontinued Ops. -- -- -- -$14.1M -$9.9M
Income Tax Expense -$221K -$5M $3M $165K $396K
Net Income to Company -- -$15.7M -$95.1M -$63.9M -$31.1M
 
Minority Interest in Earnings -$385K -$39K -$375K $470K -$119K
Net Income to Common Excl Extra Items -$8.3M -$15.7M -$95.5M -$77.6M -$41.1M
 
Basic EPS (Cont. Ops) -$0.25 -$0.47 -$2.76 -$2.18 -$1.12
Diluted EPS (Cont. Ops) -$0.25 -$0.47 -$2.76 -$2.18 -$1.12
Weighted Average Basic Share $66.6M $99.9M $103.2M $106.9M $111.5M
Weighted Average Diluted Share $66.6M $99.9M $103.2M $106.9M $112.2M
 
EBITDA $720K -$4.5M -$50.8M -$35.5M -$2.4M
EBIT -$8.4M -$19.6M -$77.1M -$51.9M -$18.2M
 
Revenue (Reported) $134.4M $251.8M $302.1M $177M $156M
Operating Income (Reported) -$8.4M -$17.8M -$76.1M -$47.6M -$21.4M
Operating Income (Adjusted) -$8.4M -$19.6M -$77.1M -$51.9M -$18.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $58.5M $90.6M $79.7M $55.8M $35.6M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $99.5M $106.3M $142.9M $116.5M $75.7M
Inventory -- -- -- -- --
Prepaid Expenses $12.3M $11.6M -- -- --
Other Current Assets -- -- $29M $26.4M $21.5M
Total Current Assets $170.3M $208.5M $251.7M $198.6M $132.8M
 
Property Plant And Equipment $29.5M $25.5M $23.1M $84.4M $58.6M
Long-Term Investments -- -- -- -- --
Goodwill -- -- $194.9M $57.6M $57.6M
Other Intangibles $15.9M $17.9M $153.1M $50.3M $49M
Other Long-Term Assets $15.5M $15.5M $14.6M $139.2M $113.6M
Total Assets $245.1M $279.2M $637.2M $530M $411.5M
 
Accounts Payable $10M $8.4M $16M $29.3M $46.4M
Accrued Expenses $18.5M $20.6M $31.4M $26.4M $15.5M
Current Portion Of Long-Term Debt -- -- -- -- $125M
Current Portion Of Capital Lease Obligations -- -- -- $23.4M $21.7M
Other Current Liabilities $1.1M $2.1M $2.7M $3.9M $4.4M
Total Current Liabilities $51.7M $57.2M $94.1M $122.9M $227.8M
 
Long-Term Debt -- $20.4M $141.9M $152.3M $33.8M
Capital Leases -- -- -- -- --
Total Liabilities $568.5M $593M $262.3M $335.4M $300.3M
 
Common Stock $4K $1K $13K $15K $15K
Other Common Equity Adj -$1.2M -$3.4M -$3.2M -$2M -$2.5M
Common Equity -$323.4M -$313.8M $370.5M $191.2M $108.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $4.3M $3.3M $2.4M
Total Equity -$323.4M -$313.8M $374.9M $194.6M $111.2M
 
Total Liabilities and Equity $245.1M $279.2M $637.2M $530M $411.5M
Cash and Short Terms $58.5M $90.6M $79.7M $55.8M $35.6M
Total Debt -- $20.4M $141.9M $152.3M $158.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- $145.6M $59.1M $42.5M $53.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $77.4M $90.1M $60.8M $49.6M
Inventory -- -- -- -- --
Prepaid Expenses -- $23.9M $33.5M -- --
Other Current Assets -- -- -- $24.3M $17.6M
Total Current Assets -- $246.8M $182.7M $127.6M $120.9M
 
Property Plant And Equipment -- $22.9M $80.7M $64.6M $41M
Long-Term Investments -- -- -- -- --
Goodwill -- $5.9M $194.1M $91.6M $57.6M
Other Intangibles -- $35.7M $144.4M $132.1M $47.2M
Other Long-Term Assets -- -- -- $15.3M $9.9M
Total Assets -- $329.8M $618M $431.2M $276.5M
 
Accounts Payable -- $12.6M $22.9M $41.6M $15M
Accrued Expenses -- $20.2M $27.4M $17.7M $20.6M
Current Portion Of Long-Term Debt -- -- -- -- $102.9M
Current Portion Of Capital Lease Obligations -- -- $25.6M $21.3M $22.8M
Other Current Liabilities -- $1.3M $1.7M $4.2M $3.2M
Total Current Liabilities -- $63.6M $110.3M $107.8M $180.3M
 
Long-Term Debt -- $19.5M $150.7M $157.1M --
Capital Leases -- -- -- -- --
Total Liabilities -- $596.9M $320.3M $309.3M $202.5M
 
Common Stock -- $6K $15K $15K $4K
Other Common Equity Adj -- -$3.1M -$2.1M -$1.8M -$4M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $1.7M $4M $2.5M $2.4M
Total Equity -- -$267.1M $297.7M $122M $74.1M
 
Total Liabilities and Equity -- $329.8M $618M $431.2M $276.5M
Cash and Short Terms -- $145.6M $59.1M $42.5M $53.7M
Total Debt -- $19.5M $150.7M $157.1M $102.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$36.9M $11.2M $3.9M -$140.5M -$60.3M
Depreciation & Amoritzation $19.5M $17.5M $22.1M $24.3M $21.9M
Stock-Based Compensation $2.8M $1.2M $23.6M $19.2M $5.6M
Change in Accounts Receivable $4.4M -$7.1M -$13M $23.9M $40.7M
Change in Inventories -- -- -- -- --
Cash From Operations -$20.2M $27.6M $797K -$7.9M -$6.1M
 
Capital Expenditures $8.6M $14.5M $16M $17.8M $14.9M
Cash Acquisitions -- -$265K -$192M -- --
Cash From Investing $16.4M -$14.8M -$208M -$17.3M -$14.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $237.3M $152.8M $5M $2.1M
Long-Term Debt Repaid -- -$218M -$1.3M -- -$1.8M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$11.7M -$2.3M -$451K
Cash From Financing $195K $19.5M $181.8M $3.2M $812K
 
Beginning Cash (CF) $77.4M $74M $106.1M $79.7M $55.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$3.7M $32.2M -$25.4M -$22M -$20M
Ending Cash (CF) $74M $106.1M $79.7M $55.8M $35.6M
 
Levered Free Cash Flow -$28.8M $13M -$15.2M -$25.6M -$21M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -$3.6M -$27M -$12M $2M
Depreciation & Amoritzation -- $5.4M $9.2M $5.4M $5M
Stock-Based Compensation -- $503K $3.6M $1.7M $1.7M
Change in Accounts Receivable -- -$1.5M -$1.1M $9M -$2.5M
Change in Inventories -- -- -- -- --
Cash From Operations -- -$4.4M -$4.1M $5.4M $9.6M
 
Capital Expenditures -- $4.1M $4.8M $3.5M $3.2M
Cash Acquisitions -- -$724K -- -- --
Cash From Investing -- -$4.8M -$4.3M -$3.5M -$3.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$479K --
Repurchase of Common Stock -- -- -$1.7M -$407K -$291K
Other Financing Activities -- -- $1.6M $220K $827K
Cash From Financing -- $294K -$35K -$529K $1.2M
 
Beginning Cash (CF) -- $154.8M $68.2M $41.3M $45.5M
Foreign Exchange Rate Adjustment -- -$305K -$622K -$129K $658K
Additions / Reductions -- -$8.9M -$8.4M $1.3M $7.6M
Ending Cash (CF) -- $145.6M $59.1M $42.5M $53.7M
 
Levered Free Cash Flow -- -$8.5M -$8.9M $1.8M $6.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -$75.6M -$109.3M -$27.5M
Depreciation & Amoritzation -- -- $33.4M $14.4M $21.3M
Stock-Based Compensation -- $850K $41.6M $4.8M $5.3M
Change in Accounts Receivable -- -- $5.6M $28M $13.7M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$18M -$2.3M -$19.9M
 
Capital Expenditures -- $9.4M $20.9M $15.2M $13M
Cash Acquisitions -- $4.5M -$196.5M -- --
Cash From Investing -- -- -$216.9M -$15M $95.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$1.8M -$65.1M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$1.7M -$951K
Cash From Financing -- -- $150.7M $927K -$65.2M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$84.2M -$16.4M $10.8M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -$38.9M -$17.5M -$32.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -$15.7M -$95.1M -$63.9M -$31.1M
Depreciation & Amoritzation -- $15M $26.3M $16.4M $15.8M
Stock-Based Compensation -- $850K $18.9M $4.5M $4.2M
Change in Accounts Receivable -- $32.2M $50.8M $54.8M $27.8M
Change in Inventories -- -- -- -- --
Cash From Operations -- $10.9M -$7.9M -$2.4M -$16.1M
 
Capital Expenditures -- $9.4M $14.3M $11.7M $9.8M
Cash Acquisitions -- $4.5M -- -- --
Cash From Investing -- -$4.9M -$13.8M -$11.5M $99.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $5M $2.1M --
Long-Term Debt Repaid -- -- -- -$1.8M -$65.1M
Repurchase of Common Stock -- -- -$1.7M -$407K -$291K
Other Financing Activities -- -- -$585K -- -$500K
Cash From Financing -- $34.3M $3.1M $856K -$65.2M
 
Beginning Cash (CF) -- $414.1M $222.5M $147M $142.6M
Foreign Exchange Rate Adjustment -- -$804K -$2M -$291K $279K
Additions / Reductions -- $40.3M -$18.6M -$13M $17.8M
Ending Cash (CF) -- $453.6M $201.9M $133.7M $160.7M
 
Levered Free Cash Flow -- $1.5M -$22.2M -$14M -$25.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock